BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22403020)

  • 1. Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    J Inherit Metab Dis; 2012 Nov; 35(6):1129-35. PubMed ID: 22403020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression and mRNA editing of serotonin receptor 2C in brains of HPRT gene knock-out mice, an animal model of Lesch-Nyhan disease.
    Bertelli M; Alushi B; Veicsteinas A; Jinnah HA; Micheli V
    J Clin Neurosci; 2009 Aug; 16(8):1061-3. PubMed ID: 19473847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine transport in peripheral blood lymphocytes from Lesch-Nyhan patients.
    Torres RJ; Deantonio I; Prior C; Puig JG
    Biochem J; 2004 Feb; 377(Pt 3):733-9. PubMed ID: 14572307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease.
    Torres RJ; Prior C; Garcia MG; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):507-516. PubMed ID: 27906640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease).
    Bertelli M; Cecchin S; Lapucci C; Jacomelli G; Jinnah HA; Pandolfo M; Micheli V
    Clin Chim Acta; 2006 Nov; 373(1-2):104-7. PubMed ID: 16793031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients.
    Prior C; Torres RJ; Puig JG
    Eur J Clin Invest; 2007 Nov; 37(11):905-11. PubMed ID: 17883419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated variants of Lesch-Nyhan disease.
    Jinnah HA; Ceballos-Picot I; Torres RJ; Visser JE; Schretlen DJ; Verdu A; Laróvere LE; Chen CJ; Cossu A; Wu CH; Sampat R; Chang SJ; de Kremer RD; Nyhan W; Harris JC; Reich SG; Puig JG;
    Brain; 2010 Mar; 133(Pt 3):671-89. PubMed ID: 20176575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.
    Lloyd KG; Hornykiewicz O; Davidson L; Shannak K; Farley I; Goldstein M; Shibuya M; Kelley WN; Fox IH
    N Engl J Med; 1981 Nov; 305(19):1106-11. PubMed ID: 6117011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine function in Lesch-Nyhan disease.
    Nyhan WL
    Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):409-11. PubMed ID: 10852837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients.
    Torres RJ; DeAntonio I; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1193-6. PubMed ID: 15571229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gilles de la Tourette syndrome: further studies and thoughts.
    Singer HS; Pepple JM; Ramage AL; Butler IJ
    Ann Neurol; 1978 Jul; 4(1):21-5. PubMed ID: 279303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease.
    López JM; Outtrim EL; Fu R; Sutcliffe DJ; Torres RJ; Jinnah HA
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12071-12079. PubMed ID: 32430324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic approach to Lesch-Nyhan disease.
    Dauphinot L; Mockel L; Cahu J; Jinnah HA; Ledroit M; Potier MC; Ceballos-Picot I
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):208-17. PubMed ID: 24940671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.
    Torres RJ; Puig JG
    J Inherit Metab Dis; 2015 Nov; 38(6):1109-18. PubMed ID: 25940910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesch-Nyhan disease: I. Construction of expression vectors for hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme and amyloid precursor protein (APP).
    Nguyen KV; Naviaux RK; Nyhan WL
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(6):905-922. PubMed ID: 32312153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.
    Baumeister AA; Frye GD
    Neurosci Biobehav Rev; 1985; 9(2):169-78. PubMed ID: 3925393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine nucleotide depletion induces differentiation and aberrant neurite outgrowth in human dopaminergic neuroblastoma lines: a model for basal ganglia dysfunction in Lesch-Nyhan disease.
    Messina E; Micheli V; Giacomello A
    Neurosci Lett; 2005 Feb; 375(2):97-100. PubMed ID: 15670649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal HPRT coding region in complete and partial HPRT deficiency.
    García MG; Torres RJ; Prior C; Puig JG
    Mol Genet Metab; 2008 Jun; 94(2):167-72. PubMed ID: 18316217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesch-Nyhan disease and the basal ganglia.
    Visser JE; Bär PR; Jinnah HA
    Brain Res Brain Res Rev; 2000 Apr; 32(2-3):449-75. PubMed ID: 10760551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.